Clinical Trial Update: A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating 14-day early bactericidal activity of nitazoxanide for tuberculosis treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED